SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001847903-23-000097
Filing Date
2023-05-12
Accepted
2023-05-12 07:14:36
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnta-20230331.htm   iXBRL 10-Q 1523167
2 EX-31.1 a20230331exhibit311.htm EX-31.1 9399
3 EX-31.2 a20230331exhibit312.htm EX-31.2 9328
4 EX-32.1 a20230331exhibit321.htm EX-32.1 5354
5 EX-32.2 a20230331exhibit322.htm EX-32.2 5168
  Complete submission text file 0001847903-23-000097.txt   5904504

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20230331.xsd EX-101.SCH 37889
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnta-20230331_cal.xml EX-101.CAL 50684
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20230331_def.xml EX-101.DEF 200037
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20230331_lab.xml EX-101.LAB 530020
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20230331_pre.xml EX-101.PRE 337504
57 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20230331_htm.xml XML 720578
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40445 | Film No.: 23913139
SIC: 2834 Pharmaceutical Preparations